BioLife Solutions, Inc.
BLFS
$23.95
-$0.79-3.19%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 1.19M | -- | 621.00K | -15.84M | -448.00K |
| Total Depreciation and Amortization | 699.00K | -- | 1.34M | 1.38M | 510.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.51M | -- | 7.14M | 21.74M | 5.43M |
| Change in Net Operating Assets | -6.88M | -- | -2.99M | 85.00K | -3.76M |
| Cash from Operations | -491.00K | -- | 6.10M | 7.37M | 1.73M |
| Capital Expenditure | -167.00K | -- | -3.68M | -1.91M | -425.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.66M | -- | -2.29M | -37.63M | -26.75M |
| Cash from Investing | -1.83M | -- | -5.97M | -39.53M | -27.18M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.50M | -- | -2.50M | -2.50M | -2.50M |
| Issuance of Common Stock | 190.00K | -- | 0.00 | 18.00K | -- |
| Repurchase of Common Stock | -5.59M | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 3.00K | -- | -58.00K | -396.00K | -492.00K |
| Cash from Financing | -7.90M | -- | -2.56M | -2.88M | -2.99M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -10.22M | -- | -2.42M | -35.04M | -28.44M |